Safi R. Bahcall

2007

In 2007, Safi R. Bahcall earned a total compensation of $884.8K as President and Chief Executive Officer at Synta Pharmaceuticals, a 19% decrease compared to previous year.

Compensation breakdown

Bonus$177,500
Option Awards$274,344
Salary$352,500
Other$80,453
Total$884,797

Bahcall received $352.5K in salary, accounting for 40% of the total pay in 2007.

Bahcall also received $177.5K in bonus, $274.3K in option awards and $80.5K in other compensation.

Rankings

In 2007, Safi R. Bahcall's compensation ranked 4,463rd out of 8,700 executives tracked by ExecPay. In other words, Bahcall earned more than 48.7% of executives.

ClassificationRankingPercentile
All
4,463
out of 8,700
49th
Division
Manufacturing
1,618
out of 3,314
51st
Major group
Chemicals And Allied Products
323
out of 746
57th
Industry group
Drugs
192
out of 546
65th
Industry
Pharmaceutical Preparations
137
out of 364
62nd
Source: SEC filing on April 30, 2010.

Bahcall's colleagues

We found four more compensation records of executives who worked with Safi R. Bahcall at Synta Pharmaceuticals in 2007.

2007

Keizo Koya

Synta Pharmaceuticals

Senior Vice President, Drug Development

2007

James Barsoum

Synta Pharmaceuticals

Senior Vice President, Research

2007

Eric Jacobson

Synta Pharmaceuticals

Chief Medical Officer

2007

Keith Ehrlich

Synta Pharmaceuticals

Chief Financial Officer

You may also like